Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure

Shigeki Sasaki; Tomohiro Hashimoto; Norihiro Obana; Hideyo Yasuda; Yoshimasa Uehara; Minoru Maeda

doi:10.1016/S0960-894X(98)00163-2

Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure

Shigeki Sasaki, Tomohiro Hashimoto, Norihiro Obana, Hideyo Yasuda, Yoshimasa Uehara, Minoru Maeda

Chemo-Pharmaceutical Sciences

Research output: Contribution to journal › Article › peer-review

18 Citations (Scopus)

Abstract

New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.

Original language	English
Pages (from-to)	1019-1022
Number of pages	4
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	8
Issue number	9
DOIs	https://doi.org/10.1016/S0960-894X(98)00163-2
Publication status	Published - May 1 1998

All Science Journal Classification (ASJC) codes

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/S0960-894X(98)00163-2

Cite this

@article{4892604db50a437da26e1e90b39133c8,

title = "Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure",

abstract = "New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.",

author = "Shigeki Sasaki and Tomohiro Hashimoto and Norihiro Obana and Hideyo Yasuda and Yoshimasa Uehara and Minoru Maeda",

year = "1998",

month = may,

day = "1",

doi = "10.1016/S0960-894X(98)00163-2",

language = "English",

volume = "8",

pages = "1019--1022",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "9",

}

TY - JOUR

T1 - Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure

AU - Sasaki, Shigeki

AU - Hashimoto, Tomohiro

AU - Obana, Norihiro

AU - Yasuda, Hideyo

AU - Uehara, Yoshimasa

AU - Maeda, Minoru

PY - 1998/5/1

Y1 - 1998/5/1

N2 - New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.

AB - New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.

UR - http://www.scopus.com/inward/record.url?scp=0032080613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032080613&partnerID=8YFLogxK

U2 - 10.1016/S0960-894X(98)00163-2

DO - 10.1016/S0960-894X(98)00163-2

M3 - Article

C2 - 9871700

AN - SCOPUS:0032080613

SN - 0960-894X

VL - 8

SP - 1019

EP - 1022

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 9

ER -

Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this